- Home
- ACLX vs PJT Comparison
ACLX vs PJT Comparison
Compare ACLX & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- PJT
- Stock Information
- Founded
- ACLX 2015
- PJT 2014
- Country
- ACLX United States
- PJT United States
- Employees
- ACLX N/A
- PJT N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- PJT Investment Managers
- Sector
- ACLX Health Care
- PJT Finance
- Exchange
- ACLX Nasdaq
- PJT Nasdaq
- Market Cap
- ACLX 3.3B
- PJT N/A
- IPO Year
- ACLX 2022
- PJT N/A
- Fundamental
- Price
- ACLX $67.96
- PJT $136.01
- Analyst Decision
- ACLX Strong Buy
- PJT Hold
- Analyst Count
- ACLX 13
- PJT 5
- Target Price
- ACLX $110.82
- PJT $148.00
- AVG Volume (30 Days)
- ACLX 617.2K
- PJT 329.7K
- Earning Date
- ACLX 05-08-2025
- PJT 05-01-2025
- Dividend Yield
- ACLX N/A
- PJT 0.74%
- EPS Growth
- ACLX N/A
- PJT 57.58
- EPS
- ACLX N/A
- PJT 4.92
- Revenue
- ACLX $107,936,000.00
- PJT $1,495,177,000.00
- Revenue This Year
- ACLX N/A
- PJT $10.02
- Revenue Next Year
- ACLX $103.84
- PJT $11.25
- P/E Ratio
- ACLX N/A
- PJT $28.42
- Revenue Growth
- ACLX N/A
- PJT 29.26
- 52 Week Low
- ACLX $47.88
- PJT $90.95
- 52 Week High
- ACLX $107.37
- PJT $190.28
- Technical
- Relative Strength Index (RSI)
- ACLX 47.21
- PJT 31.49
- Support Level
- ACLX $68.56
- PJT $140.92
- Resistance Level
- ACLX $72.68
- PJT $150.03
- Average True Range (ATR)
- ACLX 3.01
- PJT 4.56
- MACD
- ACLX -0.31
- PJT 0.26
- Stochastic Oscillator
- ACLX 18.14
- PJT 13.35
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.